On another front, caffeine metabolism via CYP1A2 exhibits an inverse correlation with PD risk, hinting at a potential protective mechanism [301], while the absence of CYP19, which produces the neuroprotective steroid 17β-estradiol, is considered a risk factor for PD [302]. This evidence concerns the gene CYP19A1 and Parkinson disease.